Nurix Therapeutics
ISIN US67080M1036
|WKN A2P85Z
Overview
Description
Nurix Therapeutics, Inc. is a clinical stage biopharmaceutical company. It engages in the business of discovering, developing, and commercializing innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer, inflammatory conditions, and other challenging diseases. The company was founded by John Kuriyan, Michael Rapé, and Arthur Weiss in 2009 and is headquartered in San Francisco, CA.
Healthcare Biopharmaceuticals Other Biopharmaceuticals United States
Financials
Key metrics
| Market capitalisation, EUR | 1,249.76 m |
| EPS, EUR | -2.70 |
| P/B ratio | 3.68 |
| P/E ratio | - |
| Dividend yield | 0.00% |
Income statement (2023)
| Revenue, EUR | 71.41 m |
| Net income, EUR | -133.51 m |
| Profit margin | -186.98% |
What ETF is Nurix Therapeutics in?
There are 14 ETFs which contain Nurix Therapeutics. All of these ETFs are listed in the table below. The ETF with the largest weighting of Nurix Therapeutics is the ARK Genomic Revolution UCITS ETF USD Accumulating.
| ETF | Weight | Investment focus | Holdings | TER | Fund size (in m EUR) | Return 1Y | WKN | ISIN |
|---|---|---|---|---|---|---|---|---|
| SPDR MSCI World Small Cap UCITS ETF | 0.02% | Equity World Small Cap | 3,474 | 0.45% | 774 | +9.19% | A1W56P | IE00BCBJG560 |
| ARK Genomic Revolution UCITS ETF USD Accumulating | 3.65% | Equity World Health Care Innovation | 40 | 0.75% | 3 | - | A408AY | IE000O5M6XO1 |
| L&G Russell 2000 US Small Cap Quality UCITS ETF | 0.03% | Equity United States Small Cap | 1,032 | 0.30% | 118 | +10.34% | A0Q8H2 | IE00B3CNHJ55 |
| Xtrackers Russell 2000 UCITS ETF 1C | 0.05% | Equity United States Small Cap | 1,499 | 0.30% | 1,165 | +9.54% | A1XEJT | IE00BJZ2DD79 |
| iShares MSCI USA Small Cap ESG Enhanced UCITS ETF (Acc) | 0.06% | Equity United States Small Cap | 1,604 | 0.43% | 1,557 | +8.22% | A0X8SB | IE00B3VWM098 |
| UBS ETF (IE) MSCI World Small Cap Socially Responsible UCITS ETF (USD) A-acc | 0.05% | Equity World Small Cap | 788 | 0.23% | 327 | +8.53% | A3CMCT | IE00BKSCBX74 |
| UBS ETF (IE) MSCI World Small Cap Socially Responsible UCITS ETF (USD) A-dis | 0.05% | Equity World Small Cap | 788 | 0.23% | 21 | +8.16% | A3CMCU | IE00BKSCBW67 |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 0.13% | Equity United States Health Care Biotech | 215 | 0.35% | 35 | +15.27% | A2JDYM | IE00BDZVHG35 |
| iShares MSCI World Small Cap UCITS ETF | 0.02% | Equity World Small Cap | 3,330 | 0.35% | 3,585 | +9.50% | A2DWBY | IE00BF4RFH31 |
| iShares Nasdaq US Biotechnology UCITS ETF | 0.13% | Equity United States Health Care Biotech | 215 | 0.35% | 476 | +15.03% | A2DWAW | IE00BYXG2H39 |
| SPDR MSCI USA Small Cap Value Weighted UCITS ETF | 0.00% | Equity United States Small Cap | 1,733 | 0.30% | 455 | +10.32% | A12HU5 | IE00BSPLC413 |
| iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc) | 0.07% | Equity World Small Cap | 2,194 | 0.35% | 62 | +8.23% | A3C14G | IE000T9EOCL3 |
| SPDR Russell 2000 US Small Cap UCITS ETF | 0.05% | Equity United States Small Cap | 1,811 | 0.30% | 2,803 | +9.59% | A1XFN1 | IE00BJ38QD84 |
| UBS ETF (IE) MSCI World Small Cap Socially Responsible UCITS ETF (hedged to EUR) A-acc | 0.05% | Equity World Small Cap | 788 | 0.26% | 5 | +6.27% | A3CMCW | IE00BKSCC785 |
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.